4. Primary lateral sclerosis Clinical trials / Disease details

Clinical trials : 5 / Drugs : 13 - (DrugBank : 6) / Drug target genes : 13 - Drug target pathways : 25

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-000142-18-FI (EUCTR)	09/05/2018	08/05/2018	Feasibility and effects of subcutaneously given combination of dexmedetomidine and ketaminein ALS pa ...	Feasibility and pharmacodynamics of subcutaneously given combination of dexmedetomidine and ketamine ...	Amyotrophic lateral sclerosis (ALS) MedDRA version: 20.1;Level: LLT;Classification code 10036704;Ter ...	Trade Name: Dexdor INN or Proposed INN: DEXMEDETOMIDINE Trade Name: Ketanest -S INN or Proposed INN: ESK ...	Turku University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 4	Finland

First Previous1Next Last